Trial
NCT01855334
L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Joslin Diabetes Center
Condition
End Stage Renal Disease
Intervention
Spironolactone
Why stopped
change of funding leading to major redesign
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-04